Quick Answer
10x Genomics, Inc. reported Net Income of -$43.54 million for fiscal year 2025.
10x Genomics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$43.54M | +76.2% |
| 2024 | -$182.63M | +28.4% |
| 2023 | -$255.10M | -53.7% |
| 2022 | -$166.00M | -185.1% |
| 2021 | -$58.22M | +89.3% |
| 2020 | -$542.73M | -1636.7% |
| 2019 | -$31.25M | +72.2% |
| 2018 | -$112.48M | -499.5% |
| 2017 | -$18.76M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.47M | +23.2% | -179.5% |
| June 30, 2025 | $34.54M | +191.1% | +200.5% |
| March 31, 2025 | -$34.36M | +42.7% | +3.9% |
| September 30, 2024 | -$35.75M | +61.6% | +5.7% |
| June 30, 2024 | -$37.90M | +39.3% | +36.8% |
| March 31, 2024 | -$59.95M | -18.1% | +35.5% |
| September 30, 2023 | -$92.99M | -121.8% | -49.0% |
| June 30, 2023 | -$62.41M | +3.2% | -23.0% |
- 10x Genomics, Inc. showed an increase of +76.2% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, 10x Genomics, Inc.’s net income has declined by 132.1% (from -$18.76 million to -$43.54 million).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: